{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:10:46Z","timestamp":1788876646759,"version":"build-2803163510"},"reference-count":198,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Viral myocarditis (VMC) represents a primary etiology of sudden cardiac death (SCD) in young populations and significantly contributes to the development of dilated cardiomyopathy (DCM). The clinical prognosis of VMC is contingent upon the precise orchestration of pathogen clearance and the prevention of deleterious immune activation. Disease progression is characterized by multifaceted immunometabolic reprogramming, regulated cell death (RCD) pathways (including pyroptosis and ferroptosis), and complex crosstalk between damaged cardiomyocytes and infiltrating immune cells. However, conventional broad-spectrum immunosuppressants often fail to provide substantial clinical benefits due to a lack of spatiotemporal specificity, which complicates the delicate balance between anti-inflammatory efficacy and the preservation of antiviral immunity. This review delineates the paradigm shift in VMC therapeutic strategies, transitioning from systemic pharmacotherapy toward precision immunomodulation mediated by advanced biomaterials, such as functionalized cardiac patches, engineered exosomes, and piezoelectric materials. By integrating breakthroughs in immunology and bioengineering, these emerging platforms offer a promising avenue for targeted intervention during the early stages of VMC. Such approaches aim to suppress pathological inflammation without compromising intrinsic antiviral capacity, ultimately preventing the progression from acute VMC to irreversible heart failure.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1939896","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:48:50Z","timestamp":1788875330000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision immunomodulation of viral myocarditis: a spatiotemporal intervention paradigm based on smart biomaterials"],"prefix":"10.3389","volume":"17","author":[{"given":"Ying","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1601307","article-title":"A comparative review of myocarditis in pediatrics versus adults: pathogenesis, diagnosis, and management","volume":"16","author":"Ricci","year":"2025","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4103\/apc.apc_236_24","article-title":"Viral myocarditis in pediatrics: A review of current diagnostic methods and future directions","volume":"18","author":"Dawood","year":"2025","journal-title":"Ann Pediatr Cardiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/v17040484","article-title":"Myocarditis and inflammatory cardiomyopathy in dilated heart failure","volume":"17","author":"Nappi","year":"2025","journal-title":"Viruses"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41467-024-44745-x","article-title":"Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2023.2180951","article-title":"Immune mechanisms of group B coxsackievirus induced viral myocarditis","volume":"14","author":"Zhang","year":"2023","journal-title":"Virulence"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1149911","article-title":"Roles of inflammasomes in viral myocarditis","volume":"13","author":"Xu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pin.12868","article-title":"Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy","volume":"70","author":"Imanaka-Yoshida","year":"2020","journal-title":"Pathol Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.131901","article-title":"Innate and adaptive immunity in acute myocarditis","volume":"404","author":"Golino","year":"2024","journal-title":"Int J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/eurheartj\/ehaa357","article-title":"Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis","volume":"41","author":"Wei","year":"2020","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02860-3","article-title":"Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence","volume":"17","author":"Sarzani","year":"2022","journal-title":"Intern Emerg Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114316","article-title":"Detection of viral infections by innate immunity","volume":"183","author":"Carty","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m109.047464","article-title":"A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy","volume":"285","author":"Gorbea","year":"2010","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.115.001993","article-title":"Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo","volume":"4","author":"Zhang","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10020-023-00717-3","article-title":"HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases","volume":"29","author":"Ren","year":"2023","journal-title":"Mol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202504.2184.v1","article-title":"The cGAS\/STING pathway: Friend or foe in regulating cardiomyopathy","volume":"14","author":"Wang","year":"2025","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70098","article-title":"The role of the interplay between macrophage glycolytic reprogramming and NLRP3 inflammasome activation in acute lung injury\/acute respiratory distress syndrome","volume":"14","author":"Luo","year":"2024","journal-title":"Clin Transl Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s11658-025-00746-2","article-title":"The crucial role of metabolic reprogramming in driving macrophage conversion in kidney disease","volume":"30","author":"Gong","year":"2025","journal-title":"Cell Mol Biol Lett"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104744","article-title":"Interleukin-34-NF-\u03baB signaling aggravates myocardial ischemic\/reperfusion injury by facilitating macrophage recruitment and polarization","volume":"95","author":"Zhuang","year":"2023","journal-title":"EBioMedicine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.121.055888","article-title":"CCL17 aggravates myocardial injury by suppressing recruitment of regulatory T cells","volume":"145","author":"Feng","year":"2022","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(24)02357-x","article-title":"Neutrophil extracellular traps in myocardial tissue drive cardiac dysfunction and adverse outcomes in patients with heart failure with dilated cardiomyopathy","volume":"17","author":"Ichimura","year":"2024","journal-title":"Circ Heart Fail"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1167-6","article-title":"Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death","volume":"569","author":"Silvestre-Roig","year":"2019","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI185218","article-title":"T cells in cardiac health and disease","volume":"135","author":"Mart\u00edn","year":"2025","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.109.213157","article-title":"Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy","volume":"106","author":"Baldeviano","year":"2010","journal-title":"Circ Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.036065","article-title":"Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy","volume":"139","author":"Bansal","year":"2019","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4396351","DOI":"10.1155\/2018\/4396351","article-title":"Regulatory role of CD4(+) T cells in myocarditis","volume":"2018","author":"Vdovenko","year":"2018","journal-title":"J Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031833","article-title":"Granzymes: The molecular executors of immune-mediated cytotoxicity","volume":"23","author":"Hay","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.103865","article-title":"Dissecting the cellular landscape and transcriptome network in viral myocarditis by single-cell RNA sequencing","volume":"25","author":"Lasrado","year":"2022","journal-title":"iScience"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2131","article-title":"An overview of the immune mechanisms of viral myocarditis","volume":"30","author":"Lasrado","year":"2020","journal-title":"Rev Med Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/circulationaha.106.683193","article-title":"Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis","volume":"116","author":"Jane-wit","year":"2007","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkaf042","article-title":"Innate immune sensor NLRP3 drives PANoptosome formation and PANoptosis","volume":"214","author":"Sharma","year":"2025","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-025-01107-6","article-title":"Pyroptosis: molecular mechanisms and roles in disease","volume":"35","author":"Broz","year":"2025","journal-title":"Cell Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.66477","article-title":"Caspase-1-mediated extracellular vesicles derived from pyroptotic alveolar macrophages promote inflammation in acute lung injury","volume":"18","author":"Qin","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41419-019-2061-8","article-title":"Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes","volume":"10","author":"Park","year":"2019","journal-title":"Cell Death Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282921","article-title":"Necrotic cardiac myocytes skew macrophage polarization towards a classically activated phenotype","volume":"18","author":"Jiang","year":"2023","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41556-023-01343-1","article-title":"Mitochondrial DNA replication stress triggers a pro-inflammatory endosomal pathway of nucleoid disposal","volume":"26","author":"Newman","year":"2024","journal-title":"Nat Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41420-022-01046-w","article-title":"Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice","volume":"8","author":"Yan","year":"2022","journal-title":"Cell Death Discov"},{"key":"B42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.redox.2018.02.013","article-title":"Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis","volume":"16","author":"Han","year":"2018","journal-title":"Redox Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14217835","article-title":"Intravenous immunoglobulin efficacy and safety in paediatric patients diagnosed with acute myocarditis","volume":"14","author":"Sorescu","year":"2025","journal-title":"J Clin Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"10459","DOI":"10.1038\/s41598-019-46888-0","article-title":"Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis","volume":"9","author":"Yen","year":"2019","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701171","article-title":"rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and Fc\u03b3Rs","volume":"200","author":"Spirig","year":"2018","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"19759","DOI":"10.1038\/s41598-022-23806-5","article-title":"Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children","volume":"12","author":"Sinkovits","year":"2022","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd004370.pub3","article-title":"Intravenous immunoglobulin for presumed viral myocarditis in children and adults","volume":"8","author":"Robinson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2082","article-title":"Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trial","volume":"23","author":"Hazebroek","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1038\/s41467-024-48524-6","article-title":"ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection","volume":"15","author":"Bazzone","year":"2024","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2017.01.001","article-title":"Transcriptional regulation of antiviral interferon-stimulated genes","volume":"25","author":"Wang","year":"2017","journal-title":"Trends Microbiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-016-0986-9","article-title":"Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-\u03b2 treatment in patients with chronic viral cardiomyopathy","volume":"105","author":"Schultheiss","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00154.2007","article-title":"Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb\/c mice","volume":"293","author":"Wang","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4428","article-title":"IRF3 and type I interferons fuel a fatal response to myocardial infarction","volume":"23","author":"King","year":"2017","journal-title":"Nat Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000072766.67150.51","article-title":"Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction","volume":"107","author":"K\u00fchl","year":"2003","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41392-025-02143-9","article-title":"Spatiotemporal transcriptomics elucidates the pathogenesis of fulminant viral myocarditis","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262211003","article-title":"Inflammasomes as potential therapeutic targets to prevent chronic active viral myocarditis-translating basic science into clinical practice","volume":"26","author":"Przytu\u0142a","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040951","article-title":"Targeting inflammatory pathways in cardiovascular disease: The inflammasome, interleukin-1, interleukin-6 and beyond","volume":"10","author":"Libby","year":"2021","journal-title":"Cells"},{"key":"B58","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1\u03b2 inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz542","article-title":"Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur Heart J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01481-4","article-title":"IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction","volume":"32","author":"Huang","year":"2024","journal-title":"Inflammopharmacology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2020.05.009","article-title":"Tocilizumab: A therapeutic option for the treatment of cytokine storm syndrome in COVID-19","volume":"51","author":"Saha","year":"2020","journal-title":"Arch Med Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/9781119453192.ch48","article-title":"Tocilizumab for fulminant programmed death 1 inhibitor-associated myocarditis","volume":"15","author":"Wang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/sla.0000000000001691","article-title":"Inflammatory and immune responses to surgery and their clinical impact","volume":"264","author":"Alazawi","year":"2016","journal-title":"Ann Surg"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1605446","article-title":"Innate immune role of IL-6 in influenza a virus pathogenesis","volume":"15","author":"Li","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112014","article-title":"The role of anti-inflammatory drugs and nanoparticle-based drug delivery models in the management of ischemia-induced heart failure","volume":"142","author":"Haley","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.03.006","article-title":"Emerging pharmacologic targets and treatments for myocarditis","volume":"161","author":"Jensen","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejim.2020.04.050","article-title":"Therapeutic strategies for virus-negative myocarditis: a comprehensive review","volume":"77","author":"De Luca","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202404264","article-title":"Chemically programmed hydrogels for spatiotemporal modulation of the cardiac pathological microenvironment","volume":"36","author":"Yu","year":"2024","journal-title":"Adv Mater"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2586","article-title":"Crosstalk between innate immunity and autophagy in viral myocarditis leading to dilated cardiomyopathy","volume":"34","author":"Wang","year":"2024","journal-title":"Rev Med Virol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2021.01.025","article-title":"Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases","volume":"123","author":"Nakkala","year":"2021","journal-title":"Acta Biomater"},{"key":"B71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40779-025-00664-6","article-title":"Engineered immune-driven theranostics for clinical cardiology","volume":"12","author":"Zheng","year":"2025","journal-title":"Mil Med Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202209041","article-title":"A matrix-metalloproteinase-responsive hydrogel system for modulating the immune microenvironment in myocardial infarction","volume":"35","author":"Chen","year":"2023","journal-title":"Adv Mater"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c05847","article-title":"Multitargeted immunomodulatory therapy for viral myocarditis by engineered extracellular vesicles","volume":"18","author":"Pei","year":"2024","journal-title":"ACS Nano"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.34133\/research.1182","article-title":"Advances in surface biofunctionalization and intelligent monitoring of vascular scaffolds","volume":"9","author":"Rafique","year":"2026","journal-title":"Res (Wash D C)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1039\/d4tb00573b","article-title":"Comparative effectiveness of myocardial patches and intramyocardial injections in treating myocardial infarction with a MitoQ\/hydrogel system","volume":"12","author":"Tan","year":"2024","journal-title":"J Mater Chem B"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.132213","article-title":"Progresses and perspectives on natural polysaccharide based hydrogels for repair of infarcted myocardium","volume":"269","author":"Rakshit","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/biom16040580","article-title":"Synthetic-polymer-based cardiac patches for MI-induced heart failure treatment: A review","volume":"16","author":"Eliwa","year":"2026","journal-title":"Biomolecules"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.067097","article-title":"Advanced cardiac patches for the treatment of myocardial infarction","volume":"149","author":"Liu","year":"2024","journal-title":"Circulation"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092902","article-title":"Hydrogels: Properties and applications in biomedicine","volume":"27","author":"Ho","year":"2022","journal-title":"Molecules"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.100978","article-title":"Hydrogel-based cardiac repair and regeneration function in the treatment of myocardial infarction","volume":"25","author":"Xu","year":"2024","journal-title":"Mater Today Bio"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1161\/circinterventions.116.004058","article-title":"Injectable shear-thinning hydrogels for minimally invasive delivery to infarcted myocardium to limit left ventricular remodeling","volume":"9","author":"Rodell","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2023.02.003","article-title":"Targeting immunoregulation for cardiac regeneration","volume":"177","author":"Li","year":"2023","journal-title":"J Mol Cell Cardiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41467-021-21682-7","article-title":"Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202400121","article-title":"A whole-course-repair system based on stimulus-responsive multifunctional hydrogels for myocardial tissue regeneration","volume":"8","author":"Liu","year":"2024","journal-title":"Small Methods"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1177\/19373341251404075","article-title":"Tissue-inducing biomaterials for cardiac tissue regeneration and repair","volume":"32","author":"Shafiq","year":"2026","journal-title":"Tissue Eng Part A"},{"key":"B86","doi-asserted-by":"publisher","first-page":"025022","DOI":"10.1088\/1748-605x\/abcff9","article-title":"Bioactive decellularized cardiac extracellular matrix-based hydrogel as a sustained-release platform for human adipose tissue-derived stromal cell-secreted factors","volume":"16","author":"Liguori","year":"2021","journal-title":"BioMed Mater"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202001689","article-title":"Effects of mesenchymal stem cell-derived paracrine signals and their delivery strategies","volume":"10","author":"Chang","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184597","article-title":"Insights into the secretome of mesenchymal stem cells and its potential applications","volume":"20","author":"Eleuteri","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114308","article-title":"Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy","volume":"185","author":"Shang","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.747398","article-title":"Mechanobiological strategies to enhance stem cell functionality for regenerative medicine and tissue engineering","volume":"9","author":"Shafiq","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.engreg.2022.03.002","article-title":"Extracellular matrix and nitric oxide based functional coatings for vascular stents","volume":"3","author":"Cheng","year":"2022","journal-title":"Eng Regener"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7921760","article-title":"Adipose-derived mesenchymal stem cells promote M2 macrophage phenotype through exosomes","volume":"2019","author":"Heo","year":"2019","journal-title":"Stem Cells Int"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145013","article-title":"The regulatory role of T cell responses in cardiac remodeling following myocardial infarction","volume":"21","author":"Kino","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2612-2","article-title":"Effects of extracellular matrix viscoelasticity on cellular behaviour","volume":"584","author":"Chaudhuri","year":"2020","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2023.10.015","article-title":"Decellularized extracellular matrix materials for treatment of ischemic cardiomyopathy","volume":"33","author":"Liu","year":"2024","journal-title":"Bioact Mater"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.07.039","article-title":"Bi-layered polyurethane - extracellular matrix cardiac patch improves ischemic ventricular wall remodeling in a rat model","volume":"107","author":"D'Amore","year":"2016","journal-title":"Biomaterials"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2015.11.025","article-title":"Mechanical control of cardiac myofibroblasts","volume":"93","author":"van Putten","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08945-9","article-title":"Selective inhibition of stromal mechanosensing suppresses cardiac fibrosis","volume":"642","author":"Cho","year":"2025","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s10237-024-01877-9","article-title":"Impact of cardiac patch alignment on restoring post-infarct ventricular function","volume":"23","author":"Janssens","year":"2024","journal-title":"Biomech Model Mechanobiol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5223(03)00739-6","article-title":"Passive ventricular constraint to improve left ventricular function and mechanics in an ovine model of heart failure secondary to acute myocardial infarction","volume":"126","author":"Pilla","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e17-01-0014","article-title":"Mechanical regulation of cardiac fibroblast profibrotic phenotypes","volume":"28","author":"Herum","year":"2017","journal-title":"Mol Biol Cell"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/stcltm\/szae103","article-title":"Mitigating murine acute and chronic Coxsackievirus B3-induced myocarditis with human right atrial appendage-derived stromal cells","volume":"14","author":"El-Shafeey","year":"2025","journal-title":"Stem Cells Transl Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2018.09.013","article-title":"Chitosan\/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats","volume":"80","author":"Chen","year":"2018","journal-title":"Acta Biomater"},{"key":"B104","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41392-021-00700-6","article-title":"Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.08.015","article-title":"Inflammation-mediated matrix remodeling of extracellular matrix-mimicking biomaterials in tissue engineering and regenerative medicine","volume":"151","author":"Xu","year":"2022","journal-title":"Acta Biomater"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201700029","article-title":"Recent progress on piezoelectric and triboelectric energy harvesters in biomedical systems","volume":"4","author":"Zheng","year":"2017","journal-title":"Adv Sci (Weinh)"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.mattod.2023.09.005","article-title":"Electroactive biomaterials synergizing with electrostimulation for cardiac tissue regeneration and function-monitoring","volume":"70","author":"Zhang","year":"2023","journal-title":"Mater Today"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121990","article-title":"Electrical stimulation of piezoelectric BaTiO3 coated Ti6Al4V scaffolds promotes anti-inflammatory polarization of macrophages and bone repair via MAPK\/JNK inhibition and OXPHOS activation","volume":"293","author":"Wu","year":"2023","journal-title":"Biomaterials"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202203168","article-title":"A polypyrrole-polycarbonate polyurethane elastomer alleviates cardiac arrhythmias via improving bio-conductivity","volume":"12","author":"Fadle Aziz","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1397261","article-title":"Can self-powered piezoelectric materials be used to treat disc degeneration by means of electrical stimulation","volume":"12","author":"Huang","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.900094","article-title":"Cardiac macrophages and their effects on arrhythmogenesis","volume":"13","author":"Xia","year":"2022","journal-title":"Front Physiol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jconrel.2020.01.027","article-title":"A conductive cell-delivery construct as a bioengineered patch that can improve electrical propagation and synchronize cardiomyocyte contraction for heart repair","volume":"320","author":"Chen","year":"2020","journal-title":"J Control Release"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2021.08.031","article-title":"Electroconductive biomaterials for cardiac tissue engineering","volume":"139","author":"Esmaeili","year":"2022","journal-title":"Acta Biomater"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s540094","article-title":"Exosomes in disease therapy: Plant-derived exosome-like nanoparticles current status, challenges, and future prospects","volume":"20","author":"Song","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106733","article-title":"Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment","volume":"190","author":"Yi","year":"2023","journal-title":"Pharmacol Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116543","article-title":"Research status and challenges of plant-derived exosome-like nanoparticles","volume":"174","author":"Bai","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2025.2479066","article-title":"Colon health benefits of plant-derived exosome-like nanoparticles via modulating gut microbiota and immunity","volume":"65","author":"Han","year":"2025","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.1c07306","article-title":"Characterization of the microRNA profile of ginger exosome-like nanoparticles and their anti-inflammatory effects in intestinal Caco-2 cells","volume":"70","author":"Yin","year":"2022","journal-title":"J Agric Food Chem"},{"key":"B119","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s13346-024-01621-x","article-title":"Plant-derived exosome-like nanoparticles for microRNA delivery in cancer treatment","volume":"15","author":"Yi","year":"2025","journal-title":"Drug Delivery Transl Res"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b00246","article-title":"Exosome-like nanoparticles from ginger rhizomes inhibited NLRP3 inflammasome activation","volume":"16","author":"Chen","year":"2019","journal-title":"Mol Pharm"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1039\/d0fo02953j","article-title":"Grapefruit-derived extracellular vesicles as a promising cell-free therapeutic tool for wound healing","volume":"12","author":"Savc\u0131","year":"2021","journal-title":"Food Funct"},{"key":"B122","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12951-025-03567-9","article-title":"Prunus mume derived extracellular vesicle-like particles alleviate experimental colitis via disrupting NEK7-NLRP3 interaction and inflammasome activation","volume":"23","author":"Lv","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00946-3","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","volume":"21","author":"Toldo","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2025.101052","article-title":"Advances in plant-derived vesicle like nanoparticles-based therapies for inflammatory diseases","volume":"20","author":"Cheng","year":"2025","journal-title":"Asian J Pharm Sci"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.7150\/thno.97096","article-title":"Exosome-like nanoparticles derived from fruits, vegetables, and herbs: Innovative strategies of therapeutic and drug delivery","volume":"14","author":"Zhao","year":"2024","journal-title":"Theranostics"},{"key":"B126","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.actbio.2025.09.013","article-title":"Nanoparticles coated with immune cell hybrid membranes for targeted delivery of Janus kinase inhibitors and synergistic treatment of autoimmune myocarditis","volume":"205","author":"Zhang","year":"2025","journal-title":"Acta Biomater"},{"key":"B127","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.09.012","article-title":"Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy","volume":"327","author":"Dash","year":"2020","journal-title":"J Control Release"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-022-03673-9","article-title":"Research progress of cell membrane biomimetic nanoparticles for tumor therapy","volume":"17","author":"Zhao","year":"2022","journal-title":"Nanoscale Res Lett"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1039\/c9bm01392j","article-title":"Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery","volume":"8","author":"Wang","year":"2020","journal-title":"Biomater Sci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114396","article-title":"A brief history of long circulating nanoparticles","volume":"188","author":"Haroon","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202305659","article-title":"Engineered macrophage membrane-coated nanoparticles with enhanced CCR2 expression promote spinal cord injury repair by suppressing neuroinflammation and neuronal death","volume":"20","author":"Gu","year":"2024","journal-title":"Small"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202502151","article-title":"CCR2-engineered macrophage membrane-coated metal-polyphenol nanozyme to enhance antioxidation activity for inhibiting the atherosclerotic progression","volume":"15","author":"Yan","year":"2026","journal-title":"Adv Healthc Mater"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c11762","article-title":"Neutrophil-like biomimic AIE nanoparticles with high-efficiency inflammatory cytokine targeting enable precise photothermal therapy and alleviation of inflammation","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201803567","article-title":"Platelet-inspired nanocells for targeted heart repair after ischemia\/reperfusion injury","volume":"29","author":"Su","year":"2019","journal-title":"Adv Funct Mater"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/sstr.202000018","article-title":"Drug targeting via platelet membrane-coated nanoparticles","volume":"1","author":"Wang","year":"2020","journal-title":"Small Struct"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202303317","article-title":"Reconstituted extracellular vesicles from human platelets decrease viral myocarditis in mice","volume":"19","author":"Beetler","year":"2023","journal-title":"Small"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Adv Mater"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics18010066","article-title":"From circulation to regeneration: Blood cell membrane-coated nanoparticles as drug delivery platform for immune-regenerative therapy","volume":"18","author":"Kim","year":"2026","journal-title":"Pharmaceutics"},{"key":"B140","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Gao","year":"2020","journal-title":"Nat Commun"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014352117","article-title":"Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines","volume":"117","author":"Rao","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B142","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2024.03.030","article-title":"Anti-inflammatory mechanisms of neutrophil membrane-coated nanoparticles without drug loading","volume":"369","author":"Zhang","year":"2024","journal-title":"J Control Release"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4206914\/v1","article-title":"T lymphocyte-macrophage hybrid membrane-coated biomimetic nanoparticles alleviate myocarditis via suppressing pyroptosis by targeting gene silencing","volume":"19","author":"Xiong","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c04655","article-title":"Biomimetic immunoregulators for the multi-target inflammation interruption in autoimmune diseases","volume":"19","author":"Liu","year":"2025","journal-title":"ACS Nano"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2022.11.016","article-title":"Neutrophil membrane-camouflaged nanoparticles alleviate inflammation and promote angiogenesis in ischemic myocardial injury","volume":"23","author":"Han","year":"2023","journal-title":"Bioact Mater"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.matt.2024.09.016","article-title":"Innate immunity-modulating nanobiomaterials for controlling inflammation resolution","volume":"7","author":"Li","year":"2024","journal-title":"Matter"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101980","article-title":"The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy","volume":"89","author":"Ala","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00019.2015","article-title":"Rebuilding the damaged heart: Mesenchymal stem cells, cell-based therapy, and engineered heart tissue","volume":"96","author":"Golpanian","year":"2016","journal-title":"Physiol Rev"},{"key":"B149","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-020-02504-8","article-title":"Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes","volume":"18","author":"Sid-Otmane","year":"2020","journal-title":"J Transl Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jcyt.2015.10.008","article-title":"The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration","volume":"18","author":"Konala","year":"2016","journal-title":"Cytotherapy"},{"key":"B151","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","article-title":"Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials","volume":"14","author":"Lotfy","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B152","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12967-020-02622-3","article-title":"Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine","volume":"18","author":"Nikfarjam","year":"2020","journal-title":"J Transl Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2018.04.012","article-title":"Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells","volume":"119","author":"Luther","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121000","article-title":"Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment","volume":"275","author":"Wei","year":"2021","journal-title":"Biomaterials"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112448","article-title":"Adipose-derived stem cell exosomes loaded with icariin attenuated M1 polarization of macrophages via inhibiting the TLR4\/Myd88\/NF-\u03baB signaling pathway","volume":"137","author":"Yan","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107823","article-title":"Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes","volume":"97","author":"Arabpour","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-019-0159-x","article-title":"Exosomes from mesenchymal stem\/stromal cells: a new therapeutic paradigm","volume":"7","author":"Yin","year":"2019","journal-title":"biomark Res"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.553444","article-title":"Scalable production of human mesenchymal stromal cell-derived extracellular vesicles under serum-\/xeno-free conditions in a microcarrier-based bioreactor culture system","volume":"8","author":"de Almeida Fuzeta","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.08.012","article-title":"Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy","volume":"503","author":"Sun","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1142\/s0192415x25500752","article-title":"Advancing traditional Chinese medicine research through network pharmacology: strategies for target identification, mechanism elucidation and innovative therapeutic applications","volume":"53","author":"Li","year":"2025","journal-title":"Am J Chin Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1039\/d4tb02091j","article-title":"Progress in Chinese medicine monomers and their nanoformulations on myocardial ischemia\/reperfusion injury","volume":"13","author":"Zhou","year":"2025","journal-title":"J Mater Chem B"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01388","article-title":"Astragaloside IV exerts cardioprotection in animal models of viral myocarditis: a preclinical systematic review and meta-analysis","volume":"10","author":"Zhuang","year":"2019","journal-title":"Front Pharmacol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2026.1770407","article-title":"Cardioprotective effects of puerarin against myocardial ischemia-reperfusion injury: a preclinical systematic review and meta-analysis","volume":"17","author":"Chen","year":"2026","journal-title":"Front Pharmacol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1643502","article-title":"Therapeutic frontiers in viral myocarditis: targeting inflammation, viruses, oxidative stress, and myocardial repair","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-025-2939-1","article-title":"Danhong injection targets CaMKII through dihydrotanshinone I to alleviate cardiomyocyte death and inflammation in viral myocarditis","volume":"69","author":"Zhang","year":"2026","journal-title":"Sci China Life Sci"},{"key":"B166","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/fcp.12232","article-title":"Research review on the pharmacological effects of astragaloside IV","volume":"31","author":"Li","year":"2017","journal-title":"Fundam Clin Pharmacol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116533","article-title":"Systems pharmacology reveals the mechanism of astragaloside IV in improving immune activity on cyclophosphamide-induced immunosuppressed mice","volume":"313","author":"Yao","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2015-0457","article-title":"Astragaloside IV protects cardiomyocytes from anoxia\/reoxygenation injury by upregulating the expression of Hes1 protein","volume":"94","author":"Huang","year":"2016","journal-title":"Can J Physiol Pharmacol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0797-z","article-title":"Wnt and Hippo pathways in regulatory T cells: a NOTCH above in asthma","volume":"21","author":"Hammad","year":"2020","journal-title":"Nat Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-019-01260-w","article-title":"Activation of the Notch signaling pathway disturbs the CD4(+)\/CD8(+), Th17\/Treg balance in rats with experimental autoimmune uveitis","volume":"68","author":"Yin","year":"2019","journal-title":"Inflammation Res"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111521","article-title":"Role of cytokines and Th17\/Tregs imbalance in the pathogenesis of otitis media with effusion. Modulation of Notch1\/Hes1\/mTORC1\/S6k1 signalling pathway underlies the protective effect of astaxanthin","volume":"128","author":"Mohamed","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-025-00621-2","article-title":"Macrophage-derived SPP1 exacerbate myocardial injury by interacting with fibroblasts in viral myocarditis","volume":"20","author":"Duan","year":"2025","journal-title":"Biol Direct"},{"key":"B173","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12951-025-03260-x","article-title":"Astragaloside IV- loaded biomimetic nanoparticles target I\u03baB\u03b1 to regulate neutrophil extracellular trap formation for sepsis therapy","volume":"23","author":"Wu","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113874","article-title":"Conductive bioadhesive hydrogel with controlled astragaloside IV release for ferroptosis-mediated cardiac repair","volume":"384","author":"Li","year":"2025","journal-title":"J Control Release"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176935","article-title":"Viral myocarditis: from molecular mechanisms to therapeutic prospects","volume":"982","author":"Yan","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathol.3.121806.151534","article-title":"Molecular biology and pathogenesis of viral myocarditis","volume":"3","author":"Esfandiarei","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"B177","article-title":"Viral myocarditis: balance between viral infection and immune response","volume":"12","author":"Liu","year":"1996","journal-title":"Can J Cardiol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1172\/jci159179","article-title":"MicroRNAs as therapeutic targets in cardiovascular disease","volume":"132","author":"Laggerbauer","year":"2022","journal-title":"J Clin Invest"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118608","article-title":"Immune cell dynamics and their role in cardiac injury: mechanisms and therapeutic implications","volume":"192","author":"Liu","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr7208","article-title":"Silicate-based therapy for inflammatory dilated cardiomyopathy by inhibiting the vicious cycle of immune inflammation via FOXO signaling","volume":"11","author":"Sun","year":"2025","journal-title":"Sci Adv"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00048","article-title":"Cardio-immunology of myocarditis: focus on immune mechanisms and treatment options","volume":"6","author":"Maisch","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade8560","article-title":"Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories","volume":"16","author":"Gross","year":"2024","journal-title":"Sci Transl Med"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1696914","article-title":"Decoding immune low-response states in sepsis: single-cell and 3D spatial transcriptomic insights into immunoparalysis","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2019.12.052","article-title":"Viral myocarditis-incidence, diagnosis and management","volume":"34","author":"Olejniczak","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.937","article-title":"The quest for new approaches in myocarditis and inflammatory cardiomyopathy","volume":"68","author":"Heymans","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1097\/00001573-199605000-00012","article-title":"Immunosuppressive and immunomodulatory treatment for myocarditis","volume":"11","author":"Maisch","year":"1996","journal-title":"Curr Opin Cardiol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2023.2193330","article-title":"Myocarditis: causes, mechanisms, and evolving therapies","volume":"27","author":"Kyaw","year":"2023","journal-title":"Expert Opin Ther Targets"},{"key":"B188","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14110","article-title":"Pathogenic pathways and therapeutic targets of inflammation in heart diseases: a focus on interleukin-1","volume":"54","author":"Del Buono","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac052","article-title":"Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis","volume":"118","author":"Carai","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s386763","article-title":"Nanomaterial-based electrically conductive hydrogels for cardiac tissue repair","volume":"17","author":"Lee","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119266","article-title":"Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: a case study using protein-loaded liposomes","volume":"582","author":"Webb","year":"2020","journal-title":"Int J Pharm"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-022-01262-y","article-title":"Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes","volume":"13","author":"Dri","year":"2023","journal-title":"Drug Delivery Transl Res"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2023.11.012","article-title":"Long-term in vivo degradation and biocompatibility of degradable pHEMA hydrogels containing graphene oxide","volume":"173","author":"Moura","year":"2024","journal-title":"Acta Biomater"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf129","article-title":"Ventricular arrhythmias following left ventricular assist device implantation: a systematic review and meta-analysis of incidence and clinical impact","volume":"27","author":"Cherbi","year":"2025","journal-title":"Europace"},{"key":"B196","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/joim.13556","article-title":"Dilated cardiomyopathy and chronic cardiac inflammation: pathogenesis, diagnosis and therapy","volume":"293","author":"Harding","year":"2023","journal-title":"J Intern Med"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.123.031454","article-title":"Diagnostic approach for suspected acute myocarditis: considerations for standardization and broadening clinical spectrum","volume":"12","author":"Martens","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202401561","article-title":"Multimaterial printing of serpentine microarchitectures with synergistic mechanical\/piezoelectric stimulation for enhanced cardiac-specific functional regeneration","volume":"20","author":"Han","year":"2024","journal-title":"Small"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1939896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:48:52Z","timestamp":1788875332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1939896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":198,"alternative-id":["10.3389\/fimmu.2026.1939896"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1939896","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1939896"}}